bexarotene has been researched along with Dermatitis Exfoliativa in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apisarnthanarax, N; Breuer-Mcham, J; Duvic, M; Talpur, R; Ward, S | 1 |
Bouwhuis, SA; el-Azhary, RA | 1 |
Bagazgoitia, L; Harto, A; Jaén, P; Muñoz, E; Pérez-Carmona, L; Ríos, L | 1 |
3 other study(ies) available for bexarotene and Dermatitis Exfoliativa
Article | Year |
---|---|
Optimizing bexarotene therapy for cutaneous T-cell lymphoma.
Topics: Algorithms; Anticarcinogenic Agents; Bexarotene; Dermatitis, Exfoliative; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypothyroidism; Middle Aged; Mycosis Fungoides; Photopheresis; Prospective Studies; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome | 2002 |
Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
Topics: Administration, Oral; Antineoplastic Agents; Bexarotene; Dermatitis, Exfoliative; Erythema; Follow-Up Studies; Humans; Lymph Nodes; Male; Middle Aged; Pruritus; Retinoid X Receptors; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes | 2005 |
Acute hyperkeratotic and desquamative reaction in a patient with Sézary syndrome treated with bexarotene.
Topics: Anticarcinogenic Agents; Bexarotene; Dermatitis, Exfoliative; Female; Humans; Keratinocytes; Middle Aged; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes | 2008 |